First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
Approval based on results from TOPAZ-1 global Phase III trial and a Chinese patient
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Subscribe To Our Newsletter & Stay Updated
